Talk:Daclatasvir

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Daclatasvir.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Wiki Education Foundation-supported course assignment

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Ellenyunac, Jennatlam, Littlemeow, Huntbryanm. Peer reviewers: Dmochizuki, Ktakamura, Lcsmith1.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 19:46, 17 January 2022 (UTC)[reply]

Classified as Stub

No side effects, interactions and contraindications sections... This does not qualify as Start. --ἀνυπόδητος (talk) 08:31, 12 September 2014 (UTC)[reply]

Revisions

I fixed stuff that got messed up. Poor sourcing (not WP:MEDRS). Wrong sections per WP:MEDMOS. Bad formatting. Badly formatted citations. Please see WP:MEDHOW Jytdog (talk) 06:17, 9 November 2016 (UTC)[reply]

Peer Review: Group 7

Question 1 (Dylan): Does the draft submission reflect a neutral point of view? If not, specify…

A: The writing in your article reflected a neutral point of view, I did not notice any bias in favor nor against the use of Daclatasvir. The article read like a typical Wikipedia topic and your group did a good job comprehensively covering and presenting the relevant information on the drug. I would also note that your citations seem a bit excessive at times (e.g. PK). Otherwise the article look good, great job! Dmochizuki (talk) 02:22, 15 November 2016 (UTC)[reply]

Question 2 (Kay): Are the points included verifiable with cited secondary sources that are freely accessible? Yes, I have verified that all citations were freely accessible full-text articles. Ktakamura (talk) 09:04, 16 November 2016 (UTC)[reply]

Question 3: I do not see any signs of plagiarism. It appears to be a summary using the authors' own words. Lcsmith1 (talk) 22:00, 15 November 2016 (UTC)[reply]

Talk:Daclatasvir

Wiki Education Foundation-supported course assignment

Classified as Stub

Revisions

Navigation menu

Search